Found 45 matching trials
Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer PHASE3 Intravesical treatment for superficial bladder cancer has been used for the...
Show More Location
Dept. of Surgery/Urology, Tor Vergata University
Learn More & Join Trial
Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers PHASE3 In Mexico the total number of confirmed cases of COVID-19 is 232, 000 and 2...
Show More Location
Hospital Universitario "José E. González"
Learn More & Join Trial
Immunological Response of Bladder Cancer Patients Under BCG PHASE3 Bladder cancer (BC) is one of the most common cancers worldwide and the mos...
Show More Location
Pontifical Catholic University of Campinas Hospital
Learn More & Join Trial
Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients NA This is a Phase II, prospective, single-arm, open-label clinical study eval...
Show More Location
P.O. "Santa Maria delle Grazie" - ASL Napoli 2 Nord
Learn More & Join Trial
The Response to Intralesional IL-2 and/or BCG Treatment for Cutaneous Metastatic Melanoma PHASE2 The investigators aim to include 100 local participants over the next 5 yea...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults PHASE2 This was a Phase II, randomized, double-blind, placebo-controlled trial con...
Show More Learn More & Join Trial
Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection. PHASE3 Until the first half of April, Colombia has more than 2,800 infected cases ...
Show More Location
Program for Research and Control in Tropical Diseases - PECET
Learn More & Join Trial
Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer PHASE2 A single-arm, two-stage, open-label, phase 2 study investigating the safety...
Show More Status
Active Not Recruiting
Location
Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer PHASE2 This phase II trial studies the safety and feasibility of utilizing acupunc...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT PHASE1 Phase I/II study: Phase 1 is an open-label, safety study, patients who prev...
Show More Location
University of California at Los Angeles
Learn More & Join Trial